Finelli A - Search Results

1

Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.

Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, Cleland S, Ferreiro-Iglesias A, Scheet P, Liu A, Wu C, Antwi SO, Larkin J, Zequi SC, Sun M, Hikino K, Hajiran A, Lawson KA, Cárcano F, Blanchet O, Shuch B, Nepple KG, Margue G, Sundi D, Diver WR, Folgueira MAAK, van Bokhoven A, Neffa F, Brown KM, Hofmann JN, Rhee J, Yeager M, Cole NR, Hicks BD, Manning MR, Hutchinson AA, Rothman N, Huang WY, Linehan WM, Lori A, Ferragu M, Zidane-Marinnes M, Serrano SV, Magnabosco WJ; BioBank Japan Project; Vilas A, Decia R, Carusso F, Graham LS, Anderson K, Bilen MA, Arciero C, Pellegrin I, Ricard S; FinnGen; Scelo G, Banks RE, Vasudev NS, Soomro N, Stewart GD, Adeyoju A, Bromage S, Hrouda D, Gibbons N, Patel P, Sullivan M, Protheroe A, Nugent FI, Fournier MJ, Zhang X, Martin LJ, Komisarenko M, Eisen T, Cunningham SA, Connolly DC, Uzzo RG, Zaridze D, Mukeria A, Holcatova I, Hornakova A, Foretova L, Janout V, Mates D, Jinga V, Rascu S, Mijuskovic M, Savic S, Milosavljevic S, Gaborieau V, Abedi-Ardekani B, McKay J, Johansson M, Phouthavongsy L, Hayman L, Li J, Lungu I, Bezerra SM, Souza AG, Sares CTG, Reis RB, Gallucci FP, Cordeiro MD, Pomerantz M, Lee GM, Freedman ML, Jeong A, Greenbe… See abstract for full author list ➔ Purdue MP, et al. Among authors: finelli a. Nat Genet. 2024 May;56(5):809-818. doi: 10.1038/s41588-024-01725-7. Epub 2024 Apr 26. Nat Genet. 2024. PMID: 38671320

2

Stricter Active Surveillance Criteria for Prostate Cancer do Not Result in Significantly Better Outcomes: A Comparison of Contemporary Protocols.

Komisarenko M, Timilshina N, Richard PO, Alibhai SM, Hamilton R, Kulkarni G, Zlotta A, Fleshner N, Finelli A. Komisarenko M, et al. Among authors: finelli a. J Urol. 2016 Dec;196(6):1645-1650. doi: 10.1016/j.juro.2016.06.083. Epub 2016 Jun 24. J Urol. 2016. PMID: 27350077

3

The uptake of active surveillance for the management of prostate cancer: A population-based analysis.

Richard PO, Alibhai SM, Panzarella T, Klotz L, Komisarenko M, Fleshner NE, Urbach D, Finelli A. Richard PO, et al. Among authors: finelli a. Can Urol Assoc J. 2016 Sep-Oct;10(9-10):333-338. doi: 10.5489/cuaj.3684. Can Urol Assoc J. 2016. PMID: 27800055 Free PMC article.

4

The uptake of active surveillance for the management of prostate cancer: A population-based analysis.

Richard PO, Alibhai SM, Panzarella T, Klotz L, Komisarenko M, Fleshner NE, Urbach D, Finelli A. Richard PO, et al. Among authors: finelli a. Can Urol Assoc J. 2016 Sep-Oct;10(9-10):E342-E346. doi: 10.5489/cuaj.4207. Epub 2016 Oct 13. Can Urol Assoc J. 2016. PMID: 27800064 Free PMC article. No abstract available.

5

Impact of Abiraterone Acetate and Enzalutamide on Symptom Burden of Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer.

Salem S, Komisarenko M, Timilshina N, Martin L, Grewal R, Alibhai S, Finelli A. Salem S, et al. Among authors: finelli a. Clin Oncol (R Coll Radiol). 2017 Sep;29(9):601-608. doi: 10.1016/j.clon.2017.03.010. Epub 2017 Apr 8. Clin Oncol (R Coll Radiol). 2017. PMID: 28395931

6

The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study.

Lawson KA, Saarela O, Abouassaly R, Kim SP, Breau RH, Finelli A. Lawson KA, et al. Among authors: finelli a. Eur Urol. 2017 Sep;72(3):379-386. doi: 10.1016/j.eururo.2017.04.033. Epub 2017 May 13. Eur Urol. 2017. PMID: 28511884

7

Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective.

Lawson KA, Saarela O, Liu Z, Lavallée LT, Breau RH, Wood L, Jewett MAS, Kapoor A, Tanguay S, Moore RB, Rendon R, Pouliot F, Black PC, Kawakami J, Drachenberg D, Finelli A. Lawson KA, et al. Among authors: finelli a. Can Urol Assoc J. 2017 Aug;11(8):232-237. doi: 10.5489/cuaj.4397. Can Urol Assoc J. 2017. PMID: 28798821 Free PMC article.

8

Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses.

Richard PO, Martin L, Lavallée LT, Violette PD, Komisarenko M, Evans AJ, Jain K, Jewett MAS, Finelli A. Richard PO, et al. Among authors: finelli a. Can Urol Assoc J. 2018 Aug;12(8):260-266. doi: 10.5489/cuaj.5065. Epub 2018 Apr 6. Can Urol Assoc J. 2018. PMID: 29629862 Free PMC article.

9

Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses?

Richard PO, Lavallée LT, Pouliot F, Komisarenko M, Martin L, Lattouf JB, Finelli A. Richard PO, et al. Among authors: finelli a. J Urol. 2018 Oct;200(4):731-736. doi: 10.1016/j.juro.2018.04.015. Epub 2018 Apr 11. J Urol. 2018. PMID: 29653161

10

Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes.

Komisarenko M, Martin LJ, Finelli A. Komisarenko M, et al. Among authors: finelli a. Transl Androl Urol. 2018 Apr;7(2):243-255. doi: 10.21037/tau.2018.03.02. Transl Androl Urol. 2018. PMID: 29732283 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters